Infinity Pharmaceuticals Stock Price - INFI

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Infinity Pharmaceuticals Inc INFI NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0185 1.9% 0.9945 1.02 0.9396 0.9531 0.976 15:59:45
Bid Price Ask Price Spread Spread % News
0.9711 1.07 0.0989 9.24% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
313 121,457 $ 0.9710997 $ 117,947 156,730 0.82 - 2.15
Last Trade Time Type Quantity Stock Price Currency
15:59:42 13 $ 0.9945 USD

Infinity Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 56.72M 57.03M $ -11.25M -0.21 - 54.16M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 1.00 5.00%

more financials information »

Infinity Pharmaceuticals News

Loading Messages....

Latest INFI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical INFI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.981.020.88010.9351831161,3590.01451.48%
1 Month1.161.180.820.9814487112,155-0.1655-14.27%
3 Months1.151.250.821.09112,391-0.1555-13.52%
6 Months1.451.800.821.2894,742-0.4555-31.41%
1 Year1.412.150.821.39176,669-0.4155-29.47%
3 Years1.213.840.822.18699,835-0.2155-17.81%
5 Years14.3018.250.824.43708,739-13.31-93.05%

Infinity Pharmaceuticals Description

Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.